REGULATION OF HUMAN ESTERASE

Details for Australian Patent Application No. 2003266271 (hide)

Owner BAYER HEALTHCARE AG

Inventors SMITH, Timothy, J.

Pub. Number AU-A-2003266271

PCT Number PCT/EP03/08878

PCT Pub. Number WO2004/020620

Priority 60/402,712 13.08.02 US; 60/475,503 04.06.03 US

Filing date 11 August 2003

Wipo publication date 19 March 2004

International Classifications

C12N 009/18 Enzymes, e.g. ligases (6.) - Carboxylic ester hydrolases

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

18 December 2003 Complete Application Filed

  Priority application(s): 60/402,712 13.08.02 US; 60/475,503 04.06.03 US

6 May 2004 Application Open to Public Inspection

  Published as AU-A-2003266271

16 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003266272-PEPTIDE MODULATORS OF TUMOUR SPECIFIC PYRUVATE KINASE SUBTYPE M2 (M2-PK)

2003266270-SKIN LIGHTENING AGENTS COMPRISING COUMARIN DERIVED FROM RESORCINOL DERIVATIVES